CSC-Driven Resistance to Radiotherapy

Radiotherapy is a common treatment for cancer, but cancer stem cells (CSCs) are often resistant to radiation, leading to treatment failure and tumor recurrence. This track investigates the mechanisms by which CSCs resist radiotherapy, including enhanced DNA repair, activation of survival pathways, and antioxidant defenses. Researchers explore strategies to sensitize CSCs to radiation by targeting these resistance mechanisms, improving the overall effectiveness of radiotherapy. By overcoming CSC-driven radioresistance, this research aims to reduce the likelihood of cancer recurrence and improve patient survival rates. This track highlights the importance of developing combination therapies that target CSCs to enhance the success of radiotherapy.

    Related Conference of CSC-Driven Resistance to Radiotherapy

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    CSC-Driven Resistance to Radiotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in